Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is 77.22% higher on its value in year-to-date trading and has touched a low of $0.77 and a high of $2.01 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CTXR stock was last observed hovering at around $1.38 in the last trading session, with the day’s gains setting it 0.02% off its average median price target of $7.00 for the next 12 months. It is also 86.0% off the consensus price target high of $10.00 offered by 2 analysts, but current levels are 65.0% higher than the price target low of $4.00 for the same period.
Currently trading at $1.40, the stock is 42.64% and 30.99% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.94 million and changing 1.45% at the moment leaves the stock 29.07% off its SMA200. CTXR registered -9.68% loss for a year compared to 6-month gain of 42.41%.
The stock witnessed a 34.62% loss in the last 1 month and extending the period to 3 months gives it a 32.08%, and is 25.00% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.99% over the week and 10.04% over the month.
Fwd P/E is 1.46. Distance from 52-week low is 81.82% and -30.35% from its 52-week high.
Citius Pharmaceuticals Inc. (CTXR) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Citius Pharmaceuticals Inc. (CTXR) is a “Buy”. 2 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Citius Pharmaceuticals Inc. is expected to release its quarterly report on 05/11/2023.The EPS is expected to shrink by -2.10% this year.
Citius Pharmaceuticals Inc. (CTXR) Top Institutional Holders
The shares outstanding are 146.15M, and float is at 133.82M with Short Float at 8.19%.
Citius Pharmaceuticals Inc. (CTXR) Insider Activity
A total of 0 insider transactions have happened at Citius Pharmaceuticals Inc. (CTXR) in the last six months, with sales accounting for 0 and purchases happening 0 times.
Citius Pharmaceuticals Inc. (CTXR): Who are the competitors?
The company’s main competitors (and peers) include Omeros Corporation (OMER) that is -52.71% lower over the past 12 months.